Please Wait.....
Report
United States Uterine Fibroids Treatment Devices Market By Mode of Treatment (Invasive Treatment, Minimally Invasive Treatment, Non-invasive Treatment), By Technology (Surgical Techniques, Laparoscopic Techniques, Ablation Techniques, Others), By Region and Competition, Forecast & Opportunities, 2020-2030F
Market Report I 2025-04-11 I 85 Pages I TechSci Research
The U.S. Uterine fibroids treatment devices market was valued at USD 512.35 million in 2024 and is projected to reach USD 776.73 million by 2030, expanding at a compound annual growth rate (CAGR) of 7.38% during the forecast period. This market is witnessing steady growth, fueled by increasing awareness of minimally invasive procedures, ongoing technological advancements, and the rising prevalence of uterine fibroids among women of reproductive age.
As both healthcare providers and patients increasingly seek effective, non-invasive, and patient-centric treatment options, the demand for advanced devices continues to grow. Uterine fibroids, or leiomyomas, impact a substantial proportion of women in the United States, particularly those aged 30 to 50. The escalating number of diagnosed cases is driving the need for advanced therapies, ranging from surgical interventions to minimally invasive procedures. Although these innovative treatments offer several benefits, the high cost associated with advanced devices and related procedures remains a significant barrier to broader adoption-especially in smaller or under-resourced healthcare facilities. Technologies such as magnetic resonance-guided focused ultrasound (MRgFUS) and robotic-assisted surgeries involve substantial initial investment, which may limit accessibility.
Key Market Drivers
Expansion of the Healthcare Sector
The growing healthcare industry in the United States is a key catalyst for the uterine fibroids treatment devices market. This growth is underpinned by rising healthcare expenditures, medical technology advancements, and increased patient awareness. In 2022, healthcare spending in the U.S. represented approximately 17.8% of the national Gross Domestic Product (GDP), significantly higher than the 11.5% average among other high-income nations. Healthcare coverage, however, remains uneven, with more comprehensive access available to populations such as the elderly, disabled, and low-income individuals through programs like Medicare and Medicaid.
As the nation's healthcare infrastructure continues to develop and access to specialized treatments becomes more widespread, the demand for minimally invasive and technologically advanced uterine fibroids treatment options is accelerating. A primary growth driver is the high prevalence of fibroids among women in the U.S.-with the Office on Women's Health (OWH) estimating that between 20% and 80% of women will develop fibroids by age 50. Consequently, there is an increasing shift toward non-surgical treatment solutions, including uterine artery embolization (UAE), MRgFUS, and laparoscopic radiofrequency ablation (RFA).
MRgFUS is a cutting-edge, non-invasive technology that utilizes geometrically focused, high-intensity ultrasound waves to target deep tissue structures without anesthesia or radiation exposure. It enables real-time imaging and precision targeting while offering additional capabilities, such as reversible blood-brain barrier (BBB) opening and neuromodulation, with potential applications extending to neurological conditions.
These advanced treatment modalities offer several clinical advantages, including shorter recovery periods, reduced complications, and improved patient outcomes, positioning them as favorable alternatives to traditional surgical procedures such as hysterectomy.
Key Market Challenges
High Costs Associated with Advanced Devices
The high cost of technologically advanced treatment devices remains a major constraint for market expansion. Devices such as MRgFUS, robotic-assisted surgical systems, and RFA tools incorporate complex engineering, high-resolution imaging technologies, and AI-integrated controls, resulting in significantly higher manufacturing and acquisition costs compared to conventional surgical instruments.
This cost barrier particularly impacts smaller hospitals and outpatient centers that may lack the capital resources to invest in these systems. Moreover, the procedures involving these devices often incur higher costs, which can result in elevated out-of-pocket expenses for patients-especially those with limited insurance coverage for emerging treatments. While these minimally invasive solutions reduce hospital stays and accelerate recovery, the financial burden continues to challenge widespread adoption.
Key Market Trends
Rising Awareness and Emphasis on Early Diagnosis
Heightened awareness of uterine fibroids and the growing importance of early diagnosis are shaping key trends in the U.S. market. The Early Detection Research Group (EDRG) supports initiatives evaluating the efficacy, performance, and clinical outcomes of early detection technologies, including advanced imaging and molecular diagnostics.
Educational campaigns, advocacy initiatives, and innovations in diagnostic methods are encouraging more women to seek early evaluation and intervention. This proactive approach is increasing demand for non-invasive treatment solutions. Public awareness efforts by organizations such as the Fibroid Foundation and the Society for Women's Health Research (SWHR) are playing a pivotal role in disseminating information about symptoms, diagnosis, and available treatments. These initiatives are helping to drive early diagnosis and improve access to less invasive therapeutic options.
Key Market Players
- Medtronic Plc
- Stryker Corporation
- Boston Scientific Corporation
- INSIGHTEC Ltd.
- CooperSurgical Inc.
Report Scope
In this report, the United States Uterine Fibroids Treatment Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
- United States Uterine Fibroids Treatment Devices Market, By Mode of Treatment:
o Invasive Treatment
o Minimally Invasive Treatment
o Non-invasive Treatment
- United States Uterine Fibroids Treatment Devices Market, By Technology:
o Surgical Techniques
o Laparoscopic Techniques
o Ablation Techniques
o Others
- United States Uterine Fibroids Treatment Devices Market, By Region:
o Northeast
o Midwest
o South
o West
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the United States Uterine Fibroids Treatment Devices Market.
Available Customizations:
United States Uterine Fibroids Treatment Devices Market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. United States Uterine Fibroids Treatment Devices Market Outlook
4.1. Market Size & Forecast
4.1.1. By Value
4.2. Market Share & Forecast
4.2.1. By Mode of Treatment (Invasive Treatment, Minimally Invasive Treatment, Non-invasive Treatment)
4.2.2. By Technology (Surgical Techniques, Laparoscopic Techniques, Ablation Techniques, Others)
4.2.3. By Region
4.2.4. By Company
4.3. Market Map
4.3.1. By Mode of Treatment
4.3.2. By Technology
4.3.3. By Region
5. Northeast Uterine Fibroids Treatment Devices Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Mode of Treatment
5.2.2. By Technology
6. Midwest Uterine Fibroids Treatment Devices Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Mode of Treatment
6.2.2. By Technology
7. South Uterine Fibroids Treatment Devices Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Mode of Treatment
7.2.2. By Technology
8. West Uterine Fibroids Treatment Devices Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Mode of Treatment
8.2.2. By Technology
9. Market Dynamics
9.1. Drivers
9.2. Challenges
10. Market Trends & Developments
10.1. Recent Developments
10.2. Product Launches
10.3. Mergers & Acquisitions
11. Policy & Regulatory Landscape
12. United States Economic Profile
13. Competitive Landscape
13.1. Medtronic Plc
13.1.1. Business Overview
13.1.2. Company Snapshot
13.1.3. Products & Services
13.1.4. Financials (In case of listed)
13.1.5. Recent Developments
13.1.6. SWOT Analysis
13.2. Stryker Corporation
13.3. Boston Scientific Corporation
13.4. INSIGHTEC Ltd.
13.5. CooperSurgical Inc.
14. Strategic Recommendations
15. About us & Disclaimer
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security